PMID- 10328999 OWN - NLM STAT- MEDLINE DCOM- 19990802 LR - 20131121 IS - 0888-7543 (Print) IS - 0888-7543 (Linking) VI - 57 IP - 3 DP - 1999 May 1 TI - Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. PG - 333-41 AB - Multiple alleles of the quaking (qk) gene have a variety of phenotypes ranging in severity from early embryonic death to viable dysmyelination. A previous study identified a candidate gene, QKI, that contains an RNA-binding domain and encodes at least three protein isoforms (QKI-5, -6 and -7). We have determined the genomic structure of QKI, identifying an additional alternative end in cDNAs. Further we have examined the exons and splice sites for mutations in the lethal alleles qkl-1, qkkt1, qkk2, and qkkt3. The mutation in qkl-1 creates a splice site in the terminal exon of the QKI-6 isoform. Missense mutations in the KH domain and the QUA1 domains in qkk2 and qkkt3, respectively, indicate that these domains are of critical functional importance. Although homozygotes for each ENU induced allele die as embryos, their phenotypes as viable compound heterozygotes with qkv differ. Compound heterozygous qkv animals carrying qkkt1, qkk2, and qkkt3 all exhibit a permanent quaking phenotype similar to that of qkv/qkv animals, whereas qkv/qkl-1 animals exhibit only a transient quaking phenotype. The qkl-1 mutation eliminates the QKI-5 isoform, showing that this isoform plays a crucial role in embryonic survival. The transient quaking phenotype observed in qkv/qkl-1 mice indicates that the QKI-6 and QKI-7 isoforms function primarily during myelination, but that QKI-5 may have a concentration-dependent role in early myelination. This mutational analysis demonstrates the power of series of alleles to examine the function of complex loci and suggests that additional mutant alleles of quaking could reveal additional functions of this complex gene. CI - Copyright 1999 Academic Press. FAU - Cox, R D AU - Cox RD AD - Oxford University, Windmill Road, Headington, Oxford, OX3 7BN, United Kingdom. r.cox@har.mrc.ac.uk FAU - Hugill, A AU - Hugill A FAU - Shedlovsky, A AU - Shedlovsky A FAU - Noveroske, J K AU - Noveroske JK FAU - Best, S AU - Best S FAU - Justice, M J AU - Justice MJ FAU - Lehrach, H AU - Lehrach H FAU - Dove, W F AU - Dove WF LA - eng SI - GENBANK/AJ012812 SI - GENBANK/AJ012813 SI - GENBANK/AJ012814 SI - GENBANK/AJ012815 SI - GENBANK/AJ012816 SI - GENBANK/AJ012817 SI - GENBANK/AJ012818 SI - GENBANK/AJ012819 SI - GENBANK/AJ012820 GR - CA07075/CA/NCI NIH HHS/United States GR - CA23076/CA/NCI NIH HHS/United States GR - CA63677/CA/NCI NIH HHS/United States GR - Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Genomics JT - Genomics JID - 8800135 RN - 0 (DNA, Complementary) RN - 0 (Mutagens) RN - 0 (Qk protein, mouse) RN - 0 (RNA-Binding Proteins) RN - P8M1T4190R (Ethylnitrosourea) SB - IM MH - Animals MH - Base Sequence MH - Chromosome Mapping MH - DNA, Complementary MH - Ethylnitrosourea/*pharmacology MH - *Genes, Lethal MH - Mice MH - Mice, Inbred C57BL MH - Mice, Quaking MH - Molecular Sequence Data MH - Mutagenesis MH - Mutagens/*pharmacology MH - RNA-Binding Proteins/drug effects/*genetics EDAT- 1999/05/18 00:00 MHDA- 1999/05/18 00:01 CRDT- 1999/05/18 00:00 PHST- 1999/05/18 00:00 [pubmed] PHST- 1999/05/18 00:01 [medline] PHST- 1999/05/18 00:00 [entrez] AID - S0888-7543(99)95804-4 [pii] AID - 10.1006/geno.1999.5804 [doi] PST - ppublish SO - Genomics. 1999 May 1;57(3):333-41. doi: 10.1006/geno.1999.5804.